T1	Outcomes 48 82	specific airway resistance changes
T2	Outcomes 442 490	that specific airway resistance changes (ΔsRAW)
T3	Outcomes 595 658	underwent dyspnea evaluation (VAS score) and pulmonary function
T4	Outcomes 744 790	RESULTS Spirographic and ΔsRAW-based criteria
T5	Outcomes 836 849	respectively.
T6	Outcomes 850 856	ΔsRAW
T7	Outcomes 873 917	changes of intrathoracic gas volume (ΔITGV)
T8	Outcomes 927 952	p<0.001), residual volume
T9	Outcomes 969 977	p<0.001)
T10	Outcomes 994 1002	p=0.001)
T11	Outcomes 1023 1038	p<0.001), while
T12	Outcomes 1046 1061	correlated only
T13	Outcomes 1116 1124	in terms
T14	Outcomes 1128 1144	ΔITGV (p=0.002)
T15	Outcomes 1151 1160	(p=0.023)
T16	Outcomes 1213 1233	stratified according
T17	Outcomes 1301 1330	bronchodilators, ΔsRAW-based
T18	Outcomes 1341 1372	is preferable to FEV1-FVC-based
T19	Outcomes 1394 1435	closely related to bronchodilator-induced
